Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+93.7%
5Y CAGR+42.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+93.7%/yr
vs +15.4%/yr prior
5Y CAGR
+42.9%/yr
Recent acceleration
Acceleration
+78.3pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $177.44M | -5.5% |
| 2024 | $187.67M | +353.5% |
| 2023 | $41.38M | +69.6% |
| 2022 | $24.40M | -22.6% |
| 2021 | $31.53M | +6.0% |
| 2020 | $29.75M | +42.4% |
| 2019 | $20.90M | +52.2% |
| 2018 | $13.73M | +41.9% |
| 2017 | $9.68M | -28.6% |
| 2016 | $13.55M | - |